| |
|
|
|
OMICS Group of Conferences, Hilton Raleigh-Durham Airport at Research Triangle,Park 4810 Page Creek Lane,Durham,North Carolina,27703,USA
September 23-25, 2013
Biosimilars-2013 will provide an excellent and global opportunity to the scientists, partners and pharmacy leaders from Bio-pharmaceutical and Biotechnology industries to innovate and to explore the strategic market for Bio-similar and Bio-waivers. The patent expiration of generics have given a gateway to Bio-similar into the Global Pharmaceutical Economy since last few years. Though the regulatory prospects upon Follow-on Biologic were not much implemented in past years, the present circumstances of pharmaceutical R&D s are worried about patent issues with generic drugs and their molecular entities.
|
|
|
|
|
|
|
|
Organized by:
|
|
OMICS Publishing Group |
|
|
Invited Speakers:
|
|
- Huixiao Hong, National Center for Toxicological Research, U.S. Food and Drug Administration, USA
- Michael Retsky, Harvard School of Public Health, USA
- Michael V Miles, Children′s Hospital Medical Center, USA
- Vladimir Tolstikov, University of California, USA
|
|
|
|
|
|
|
|
Deadline for Abstracts:
|
|
September 23, 2013
|
|
|
|
|
|
|
|
Registration:
|
|
Register here
|
|
|
E-mail:
|
|
biosimilars2013@omicsonline.com
|
|
|
|
|
|
|
|
|